BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Egesel T, Büyükasik Y, Dündar SV, Gürgey A, Kirazli S, Bayraktar Y. The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis. J Clin Gastroenterol. 2000;30:66-71. [PMID: 10636214 DOI: 10.1097/00004836-200001000-00013] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Naeshiro N, Aikata H, Hyogo H, Kan H, Fujino H, Kobayashi T, Fukuhara T, Honda Y, Nakahara T, Ohno A. Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis. Hepatol Res. 2015;45:656-662. [PMID: 25088236 DOI: 10.1111/hepr.12400] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
2 Specchi S, Pey P, Ledda G, Lustgarten M, Thrall D, Bertolini G. COMPUTED TOMOGRAPHIC AND ULTRASONOGRAPHIC CHARACTERISTICS OF CAVERNOUS TRANSFORMATION OF THE OBSTRUCTED PORTAL VEIN IN SMALL ANIMALS: Cavernous Transformation of the Portal Vein. Vet Radiol Ultrasound 2015;56:511-9. [DOI: 10.1111/vru.12265] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
3 McCormick PA, Murphy KM. Splenomegaly, hypersplenism and coagulation abnormalities in liver disease. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:1009-1031. [PMID: 11139352 DOI: 10.1053/bega.2000.0144] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 4.0] [Reference Citation Analysis]
4 Wang L, Li ZS, Lu JP, Wang F, Liu Q, Tian JM. Cavernous transformation of the portal vein: three-dimensional dynamic contrast-enhanced MR angiography. Abdom Imaging. 2008;33:463-468. [PMID: 17703273 DOI: 10.1007/s00261-007-9292-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
5 Bayraktar Y, Harmanci O. Etiology and consequences of thrombosis in abdominal vessels. World J Gastroenterol. 2006;12:1165-1174. [PMID: 16534866 DOI: 10.3748/wjg.v12.i8.1165] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 48] [Article Influence: 4.0] [Reference Citation Analysis]
6 Dutta AK, Chacko A, George B, Joseph JA, Nair SC, Mathews V. Risk factors of thrombosis in abdominal veins. World J Gastroenterol. 2008;14:4518-4522. [PMID: 18680232 DOI: 10.3748/wjg.14.4518] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
7 Amitrano L, Guardascione MA, Ames PR, Margaglione M, Antinolfi I, Iannaccone L, Annunziata M, Ferrara F, Brancaccio V, Balzano A. Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease. Am J Hematol 2003;72:75-81. [PMID: 12555209 DOI: 10.1002/ajh.10254] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
8 Kapoor S, Pal S, Sahni P, Chattopadhyay TK. Thromboelastographic evaluation of coagulation in patients with extrahepatic portal vein thrombosis and non-cirrhotic portal fibrosis: a pilot study. J Gastroenterol Hepatol. 2009;24:992-997. [PMID: 19220674 DOI: 10.1111/j.1440-1746.2008.05761.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
9 El-Karaksy H, El-Raziky M. Splanchnic vein thrombosis in the mediterranean area in children. Mediterr J Hematol Infect Dis 2011;3:e2011027. [PMID: 21869913 DOI: 10.4084/MJHID.2011.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
10 Bayraktar Y, Harmanci O, Büyükasik Y, Shorbagi AI, Sungur AH, Boylu CA, Gürgey A, Balkanci F. JAK2V617F mutation in patients with portal vein thrombosis. Dig Dis Sci 2008;53:2778-83. [PMID: 18343999 DOI: 10.1007/s10620-008-0225-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
11 Özaslan E, Dağli N, Balkanci F, Bayraktar Y. Absence of the Common Bile Duct and Junction of the Cystic Duct With the Left Hepatic Duct in a Patient With Chronic Portal Vein Thrombosis: . Journal of Clinical Gastroenterology 2002;34:280-1. [DOI: 10.1097/00004836-200203000-00018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 El-Karaksy H, El-Koofy N, El-Hawary M, Mostafa A, Aziz M, El-Shabrawi M, Mohsen NA, Kotb M, El-Raziky M, El-Sonoon MA, A-Kader H. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study. Ann Hematol 2004;83:712-5. [PMID: 15309526 DOI: 10.1007/s00277-004-0921-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
13 Harmanci O, Ersoy O, Gurgey A, Buyukasik Y, Gedikoglu G, Balkanci F, Sivri B, Bayraktar Y. The Etiologic Distribution of Thrombophilic Factors in Chronic Portal Vein Thrombosis. Journal of Clinical Gastroenterology 2007;41:521-7. [DOI: 10.1097/01.mcg.0000225635.52780.47] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
14 Hwang S, Kim do Y, Kim M, Chon YE, Lee HJ, Park YN, Park JY, Ahn SH, Han KH, Chon CY. [Deficiencies in proteins C and S in a patient with idiopathic portal hypertension accompanied by portal vein thrombosis]. Korean J Hepatol. 2010;16:176-181. [PMID: 20606502 DOI: 10.3350/kjhep.2010.16.2.176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
15 Sobhonslidsuk A, Reddy KR. Portal vein thrombosis: a concise review. Am J Gastroenterology 2002;97:535-41. [DOI: 10.1111/j.1572-0241.2002.05527.x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 84] [Article Influence: 5.6] [Reference Citation Analysis]
16 Ahluwalia J, Naseem S, Sachdeva MUS, Bose P, Bose SK, Kumar N, Thapa BR, Varma N, Chawla YK. Paroxysmal Nocturnal Hemoglobinuria is rare cause for thrombosis of the intra-abdominal veins in the ethnic Indian population - results from FLAER-based flowcytometry screening. Eur J Haematol 2014;92:435-43. [DOI: 10.1111/ejh.12265] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
17 Harmanci O, Buyukasik Y, Kirazli S, Balkanci F, Bayraktar Y. Does endothelium agree with the concept of idiopathic hepatic vessel thrombosis? World J Gastroenterol 2006;12:1273-7. [PMID: 16534884 DOI: 10.3748/wjg.v12.i8.1273] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
18 Heller C, Schobess R, Kurnik K, Junker R, Günther G, Kreuz W, Nowak-Göttl U. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group. Br J Haematol 2000;111:534-9. [PMID: 11122096 DOI: 10.1046/j.1365-2141.2000.02349.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 68] [Article Influence: 4.5] [Reference Citation Analysis]
19 Gürakan F, Eren M, Koçak N, Yüce A, Ozen H, Temizel IN, Demir H. Extrahepatic portal vein thrombosis in children: etiology and long-term follow-up. J Clin Gastroenterol. 2004;38:368-372. [PMID: 15087698 DOI: 10.1097/00004836-200404000-00013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
20 Choung H, Kim H, Gwak G, Kim S, Kim D. Inherited protein S deficiency as a reszult of a large duplication mutation of the PROS1 gene detected by multiplex ligation-dependent probe amplification. Journal of Thrombosis and Haemostasis 2008;6:1430-2. [DOI: 10.1111/j.1538-7836.2008.03026.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
21 Prabhakar A, Chatterjee T, Bajaj N, Tyagi T, Sahu A, Gupta N, Kumari B, Nair V, Kumar B, Ashraf MZ. Venous thrombosis at altitude presents with distinct biochemical profiles: a comparative study from the Himalayas to the plains. Blood Adv 2019;3:3713-23. [PMID: 31765479 DOI: 10.1182/bloodadvances.2018024554] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
22 Ogren M, Bergqvist D, Björck M, Acosta S, Sternby NH. High incidence of concomitant venous thromboembolism in patients with portal vein thrombosis: a population study based on 23 796 consecutive autopsies. J Thromb Haemost 2007;5:198-200. [PMID: 17059416 DOI: 10.1111/j.1538-7836.2006.02264.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
23 Rajesh S, Mukund A, Arora A. Imaging Diagnosis of Splanchnic Venous Thrombosis. Gastroenterol Res Pract 2015;2015:101029. [PMID: 26600801 DOI: 10.1155/2015/101029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
24 Qi X, De Stefano V, Su C, Bai M, Guo X, Fan D. Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis. Medicine (Baltimore) 2015;94:e496. [PMID: 25634200 DOI: 10.1097/MD.0000000000000496] [Cited by in Crossref: 33] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
25 Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol 2002;70:126-32. [DOI: 10.1002/ajh.10103] [Cited by in Crossref: 74] [Cited by in F6Publishing: 61] [Article Influence: 3.9] [Reference Citation Analysis]
26 Ayala R, Grande S, Bustelos R, Ribera C, García-Sesma A, Jimenez C, Moreno E, Martínez-López J. Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients. BMC Gastroenterol 2012;12:114. [PMID: 22909075 DOI: 10.1186/1471-230X-12-114] [Cited by in Crossref: 36] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
27 Samonakis DN, Koutroubakis IE, Sfiridaki A, Malliaraki N, Antoniou P, Romanos J, Kouroumalis EA. Hypercoagulable states in patients with hepatocellular carcinoma. Dig Dis Sci 2004;49:854-8. [PMID: 15259509 DOI: 10.1023/b:ddas.0000030099.13397.28] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
28 Cagin YF, Bilgic Y, Berber İ, Yildirim O, Erdogan MA, Firat F, Arslan AK, Colak C, Seckin Y, Harputluoglu M. The risk factors of portal vein thrombosis in patients with liver cirrhosis. Exp Ther Med 2019;17:3189-94. [PMID: 30936992 DOI: 10.3892/etm.2019.7300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 Weiss B, Shteyer E, Vivante A, Berkowitz D, Reif S, Weizman Z, Bujanover Y, Shapiro R. Etiology and long-term outcome of extrahepatic portal vein obstruction in children. World J Gastroenterol 2010;16:4968-72. [PMID: 20954284 DOI: 10.3748/wjg.v16.i39.4968] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
30 Kikuchi K, Rudolph R, Murakami C, Kowdley K, McDonald GB. Portal vein thrombosis after hematopoietic cell transplantation: frequency, treatment and outcome. Bone Marrow Transplant 2002;29:329-33. [PMID: 11896430 DOI: 10.1038/sj.bmt.1703368] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
31 Ayala R, Martínez-López J, Cedena T, Bustelos R, Jimenez C, Moreno E, Ribera C. Recipient and donor thrombophilia and the risk of portal venous thrombosis and hepatic artery thrombosis in liver recipients. BMC Gastroenterol 2011;11:130. [PMID: 22123067 DOI: 10.1186/1471-230X-11-130] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
32 Rodriguez-luna H, Vargas HE. Portal and Splenic Vein Thrombosis. Zakim and Boyer's Hepatology. Elsevier; 2006. pp. 905-14. [DOI: 10.1016/b978-1-4160-3258-8.50052-8] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
33 Heller C, Schobess R, Kurnik K, Junker R, Günther G, Kreuz W, Nowak-göttl U; for the Childhood Thrombophilia Study Group. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study: Abdominal Venous Thrombosis in Infancy. British Journal of Haematology 2000;111:534-9. [DOI: 10.1111/j.1365-2141.2000.02349.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
34 Nakanuma Y, Tsuneyama K, Ohbu M, Katayanagi K. Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract. 2001;197:65-76. [PMID: 11261820 DOI: 10.1078/0344-0338-5710012] [Cited by in Crossref: 75] [Cited by in F6Publishing: 52] [Article Influence: 3.8] [Reference Citation Analysis]
35 DeLeve LD, Valla DC, Garcia-Tsao G;  American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology. 2009;49:1729-1764. [PMID: 19399912 DOI: 10.1002/hep.22772] [Cited by in Crossref: 599] [Cited by in F6Publishing: 411] [Article Influence: 49.9] [Reference Citation Analysis]